UCLA Clinical and Translational Science Institute

UCLA Clinical and Translational Science Institute

Mission Statement

The mission of the UCLA CTSI is to produce and implement innovations that impact the greatest health needs of Los Angeles and the nation. Our vision is to catalyze research that translates discoveries into tangible improvements in health care, disease prevention, and health in our community.

At a Glance

0

Educational Resources Posted

3

Consortium News Stories Posted

3

Events Posted

0

Opportunities Posted

131

Publications citing CTSA Program Grant

20

Users from Hub Registered

Consortium News

One of the first synergy papers supported by the CLIC and CTSA consortium was published in the Journal of Clinical and Translational Science. Abstract: A primary barrier to translation of clinical research discoveries into care delivery and population health is the lack of sustainable infrastructure bringing researchers, policymakers, practitioners, and communities together to reduce silos in
Celebrating ten years of shared infrastructure and programs that accelerate research and improve health, UC BRAID convened its annual meeting on October 14-15, 2019 at the UCLA Luskin Conference Center. UC BRAID, the University of California Biomedical Research Acceleration, Integration, & Development, is a consortium of the five UC academic medical centers—Davis, Irvine, Los Angeles, San Diego
UCLA's David Shackelford and colleagues have identified a new biomarker that could indicate how likely someone is to respond to treatment for lung cancer. In a test using mice, the scientists found that the level of activity of the mitochondria in lung tumor cells could potentially predict who would respond favorably to a type of drug called a complex I inhibitor, which targets mitochondrial
Hwang flyer_UCLA CTSI
-
University Of California Los Angeles

Dr. Hwang is an Attending Radiologist within the Division of Body Imaging, Director of Neonatal Imaging, and an Assistant Professor of Radiology at the University of Pennsylvania. Her KL2 project is on the validation of quantitative brain contrast enhanced ultrasound for evaluation of brain health in porcine model and infants of brain injury. Required registration at https://uclahs.fyi/Hwang to

Hicks - UCLA Visiting Scholar
-
University Of California Los Angeles

Dr. Steven Hicks, MD, PhD is an Associate Professor of Pediatrics at Penn State University. His translational research identifies molecular biomarkers that inform child growth, neurodevelopment and disease. ABSTRACT: Mild traumatic brain injury (mTBI) is extremely common among adolescents, who suffer disproportionately from prolonged concussion symptoms - a condition for which no biologic test

California Precision Health Summit Feb. 6-7 at UCLA
-
University Of California Los Angeles

Please join us for the inaugural California Precision Health Summit Feb. 6-7 at UCLA. The summit will focus on cancer: tumor evolution, liquid biopsies, and immuno-oncology. Featured speakers include: - Christina Curtis, PhD, MSc - Caroline Dive, CBE - Antoni Ribas, MD, PhD - Charles Swanton, FRS, FMedSci, FRCP - Peter Van Loo, PhD Register online by Dec. 14

Poster Sessions

University Of California Los Angeles

Recognizing the diversity of populations within California and the disproportionate burden of COVID-19 on minority and low income communities, we have formed a statewide community-partnered collaborative funded by the NIH/NHLBI to address disparities in COVID-19 knowledge, awareness, and communication; vaccine trial participation; and vaccine hesitancy and accessibility. The statewide

Precision Health and Population Health Programs at UCLA CTSI, A Multi-institutional CTSA Hub
University Of California Los Angeles

UCLA CTSI Population Health Program Population health seeks to identify and address variation in needs, care experiences, intervention efficacy, and outcomes for a defined group. In health systems, closing gaps often require collective actions of complex interdependent medical and social care systems in communities. The CTSI co-developed a Population Health Program with the local health department

Publications

Role of CTSA Institutes and Academic Medical Centers in Facilitating Preapproval Access to Investigational Agents and Devices During the COVID-19 Pandemic

Introduction: With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to investigational agents and/or medical devices: Expanded Access, Emergency Use Authorizations, and Clinical Trials. Regulatory units

A Multi-Dimensional Characterization of Aging and Wellbeing Among HIV-Positive Adults in Malawi

There is relatively little research on aging with HIV and wellbeing in sub-Saharan Africa. A cross-sectional survey was implemented in Malawi; eligible respondents were ≥ 30 years old and on ART for ≥ 2 years. Univariate and multiple regression analyses were stratified by age (younger adults: aged

Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus-co-infected patients in Myanmar

Access to hepatitis C virus (HCV) testing and treatment is limited in Myanmar. We assessed an integrated HIV and viral hepatitis testing and HCV treatment strategy. Sofosbuvir/velpatasvir (SOF/VEL) ± weight-based ribavirin for 12 weeks was provided at three treatment sites in Myanmar and sustained